Stuttering is a speech fluency disorder characterised by repetitions, prolongations, hesitations, pauses and/or blocks of phonemes, syllables and words. Considering its origin, stuttering can be developmental or acquired. Associated symptoms can be manifested not only in speech, but in physical, physiological and social status. Neurogenic stuttering is a lesser-known type of acquired stuttering predominantly caused by a stroke. The purpose of this review is to give an insight into given etiologic factors, symptomatology, differential diagnostics and therapeutic methods associated with neurogenic stuttering according to recent literature. The mechanism of incurrence is not entirely known, but the majority of contemporary authors implicate the role of basal ganglia system within such a mechanism. Neurogenic stuttering frequently coexists with aphasia and motoric speech impairments such as dysarthria, apraxia and palilalia, thus complicating the diagnostic process. Aside from these accompanying disorders, there are also numerous on-going dissidences in differentiating stuttering diagnoses, according to the opinion that observable symptoms are not the only distinctive characteristic of discrete stuttering categories. In terms of alleviating symptoms, behavioural therapy is the most common form of therapy used in response to a stuttering diagnosis while drugs are used less, largely due to the side effects of pharmaceutical medication, and the ever-present risk of misuse. At present, further research is required to accurately explain and approach to aforementioned disorder